WINT

Windtree Therapeutics News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -2.07% 1.89 18:18:30
Open Price Low Price High Price Close Price Prev Close
1.88 1.85 1.93 1.90 1.93
more quote information »

Recent News

Date Time Source Heading
9/20/202107:02EDGARCurrent Report Filing (8-k)
8/05/202117:09SEEKWindtree TherapeuticS EPS misses by $0.94
7/06/202116:05EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202107:30PRNUSWindtree Appoints Diane Carman, Esq. as Senior Vice..
6/16/202117:25EDGARCurrent Report Filing (8-k)
5/13/202107:36EDGARCurrent Report Filing (8-k)
5/13/202107:30PRNUSWindtree Therapeutics Reports First Quarter 2021 Financial..
5/13/202107:15EDGARQuarterly Report (10-q)
4/30/202117:25EDGARCurrent Report Filing (8-k)
4/30/202117:24EDGARProxy Statement (definitive) (def 14a)
4/20/202107:45EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202107:49EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202107:48EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202107:00PRNUSWindtree Therapeutics Announces New Istaroxime Expedited..
4/08/202116:17EDGARStatement of Changes in Beneficial Ownership (4)
4/07/202116:19EDGARStatement of Changes in Beneficial Ownership (4)
4/06/202116:29EDGARStatement of Changes in Beneficial Ownership (4)
4/05/202108:07EDGARStatement of Changes in Beneficial Ownership (4)
4/02/202117:14EDGARStatement of Changes in Beneficial Ownership (4)
3/31/202116:30EDGARStatement of Changes in Beneficial Ownership (4)
3/29/202117:29SEEKWindtree TherapeuticS EPS beats by $0.01
3/29/202117:28EDGARCurrent Report Filing (8-k)
3/29/202117:25EDGARAnnual Report (10-k)
3/29/202117:10PRNUSWindtree Therapeutics Reports Fourth Quarter and Year End..
3/25/202119:32EDGARStatement of Changes in Beneficial Ownership (4)
3/25/202119:08EDGARStatement of Changes in Beneficial Ownership (4)
3/25/202119:08EDGARStatement of Changes in Beneficial Ownership (4)
3/25/202116:15PRNUSWindtree Therapeutics Announces Closing of $30.0 Million..
3/24/202117:15EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/23/202111:08SEEKWindtree Therapeutics slumps on pricing $30M stock offering
3/23/202108:30PRNUSWindtree Therapeutics Announces Pricing of $30.0 Million..
3/22/202116:40EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/22/202116:20SEEKWindtree Therapeutics under pressure on stock offering
3/22/202116:05PRNUSWindtree Therapeutics Announces Proposed Public Offering of..
3/22/202115:54EDGARCurrent Report Filing (8-k)
3/22/202107:00PRNUSWindtree Extends Scientific Collaboration in Heart Failure..
3/15/202107:00PRNUSWindtree to Present at the Oppenheimer 31st Annual..
3/08/202107:00PRNUSWindtree to Present at the H.C. Wainwright Global Life..
2/19/202116:40EDGARCurrent Report Filing (8-k)
2/16/202107:00PRNUSWindtree Announces Issuance of New U.S. Patent Covering..
2/12/202116:33EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/12/202116:28EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/09/202116:26EDGARInitial Statement of Beneficial Ownership (3)
2/09/202107:30EDGARCurrent Report Filing (8-k)
2/04/202108:30PRNUSWindtree Strengthens Its Board by Appointing Three New..
2/01/202116:30PRNUSWindtree Appoints Dr. Joseph Soffer to Lead Cardiovascular..
1/26/202116:40EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202116:36EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202116:35EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202116:33EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
WINT
Windtree T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.